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Abstract
The principal factors that lead to proliferation and pluripotency in embryonic stem cells (ESCs) have been vigorously
investigated. However, the global network of factors and their full signaling cascade is still unclear. In this study, we found
that ECAT11 (L1td1) is one of the ESC-associated transcripts harboring a truncated fragment of ORF-1, a component of
theL1 retrotransposable element. We generated an ECAT11 knock-in mouse by replacing its coding region with green
fluorescent protein. In the early stage of development, the fluorescence was observed at the inner cell mass of blastocysts
and epiblasts. Despite this specific expression, ECAT11-null mice grow normally and are fertile. In addition, ECAT11 was
dispensable for both the proliferation and pluripotency of ESCs.We found rapid and robust activation of ECAT11 in
fibroblasts after the forced expression of transcription factors that can give rise pluripotency in somatic cells.However, iPS
cells could be established from ECAT11-null fibroblasts. Our data demonstrate thedispensability of ECAT11/L1td1 in
pluripotency, despite its specific expression.
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Introduction
Embryonic stem cells (ESCs) have been established from
mammalian blastocysts [1],[2],[3]. ESCs have the ability to
proliferate vigorously and differentiate into various cell types.
Therefore, they are attractive sources for cell transplantation
therapy and basic research. ESCs have been used for functional
analyses of numerous genes and differentiation processes.
Recently, induced pluripotent stem cells (iPSCs) were derived
from mouse and human somatic cells that have similar
differentiation potential to ESCs, and can overcome the ethical
problems and immune rejection associated with ESCs
[4],[5],[6].
The molecular mechanisms and pathways underlying the
pluripotency and proliferation of ESCs and iPSCs are still
unclear. In mouse ESCs, pluripotency can be maintained by
leukemia inhibitory factor (LIF) and several transcription factors.
LIF activates Stat3 signaling and its downstream cascades [7] that
are involved in pluripotency. Oct4 [8], Sox2 [9] and Nanog
[10],[11] are also pivotal regulators, and maintain the undiffer-
entiated state of ESCs. Klf4 [12] is also an important factor for
the maintenance of ESCs. The Kluppel-like factor (Klf) family,
involving Klf4, Klf2 and Klf5, regulates the self-renewal of ESCs
[12]. Therefore, pluripotency is maintained by the regulatory
networks of many transcription and other factors.
To identify new genes involved in the molecular network of
pluripotency, we have previously performed a digital differential
display analysis (DDD) of the expressed sequence tag libraries
among various mouse tissues and cell lines [10],[13],[14],[15],
[16],[17]. Candidates were selected based on their specific
expression in ESCs, and included many well-known pluripotency
related genes, such as Oct4 and Nanog, as well as a variety of novel
genes which we designated the ‘‘ECATs’’ for ES cell-associated
transcripts. We have shown that ECAT4 encodes the transcription
factor Nanog, which plays critical roles in pluripotency [10],
whereas ECAT5 encodes Eras, which promotes the proliferation of
mouse ESCs [14].
In this study, we evaluated the expression and function of
another ECAT, ECAT11, also known as L1ltd1. Wegenerated
ECAT11 knock-outmice and ES cells by inserting the enhanced
green fluorescent gene (EGFP) cDNA into the ECAT11 locus.
Our study showed that ECAT11 is dispensable for the
development and maintenance of pluriptotency, despite its specific
expression pattern. We also found that ECAT11 is rapidly
activated by Oct3/4, Sox2 and Klf4 in fibroblasts, but is
dispensable for the generation of iPSCs.
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20461Figure 1. Protein structure andexpression of ECAT11. (A) Amino acid sequences of ECAT11 from various species. The boxes indicate the
conserved Transposase_22 motif. Double asterisks indicate equivalent regions of arginin residues responsible for the RNA binding activity of L1ORF1.
Black letters on a white background; non-similar residues, blue letters on a cyan background; consensus residues derived from a block of similar
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ECAT11 expression, protein structure and localization in
mouse ESCs
We identified ECAT11 by a digital differential display analysis
of expressed sequence tag (EST) databases [10] as a novel
transcript enriched in mouse ESCs. The predicted ECAT11 open
reading frame encodes 848 amino acids, showing a similarity to
ORF-1, one of the two protein components of the L1 transposable
element (L1). L1 is a non-LTR type of retrotransposon, which can
move within the genome as a transcribed RNA intermediate.
There are .599,000 copies of L1 that occupy 19% of the mouse
genome [18]. L1 encodes two proteins, ORF1 and ORF2. ORF1
has a Transposase_22 motif, which is responsible for the RNA
binding activity of ORF1 [19],[20],[21]. ORF2 encodes a protein
with an endonuclease and reverse-transcriptase activity. ORF1 is
mainly localized inthe cytoplasm as an RNA-protein particle,
together with ORF2, and supportsthe L1 transition [22]. In the C-
terminus of ECAT11, we found high homology with the C-
terminus ofthe ORF of L1 TFspa, a subtype of L1 [23]. The
identity of the protein sequence in this region was 33% (Figure 1A
motif2). The N-terminus of ECAT11 also showed homology with
Transposase_22, withan identity of 30% (Figure 1A motif1).
ECAT11 paralogs can be identified in humans, rhesus
macaques, rats and dogs (Figure 1A). The overall identity of these
proteins to mouse ECAT11 is relatively low (,23.1%), but the
second ORF1-like domain showed 45.8% identity with the mouse
protein. The identity of the first ORF1-like domain is 43.4%,
excluding dog ECAT11, which lacks this region. However, two
arginine residues (R297 and R298) of the L1 TFspa ORF1, which
are critical for its RNA binding and chaperone activity [24], are
not conserved in ECAT11. Therefore, it was unclear whether
ECAT11 hadRNA binding and chaperone activity.
An RT-PCR analysis confirmed that ECAT11 is abundantly
expressed in mouse ESCs and is suppressed upon differentiation
induced by retinoic acid (Figure 1B). The expression was
undetectable in most of adult somatic tissues, however, weak
expression was observed in the testes, ovaries, and brain. In
humans, ECAT11 transcripts were identified in ESCs, an
embryonic tumor cell line, testes, ovaries, spleen, and placenta
(Figure 1B). As a result, the expression pattern of ECAT11 seems
to be similar between mice and humans.
Generation of ECAT11-EGFP knock-in mice and ESCs
To elucidate the effect of ECAT11disruption and pursue its
expression, we generated an ECAT11-EGFP knock-in construct
on a bacterial artificial chromosome (BAC) vector. We
first replaced the protein cording region of ECAT11 with
anEGFP-IRES-Puro cassetteby enzyme-mediated recombina-
tion (Figure 2A). The manipulated BAC was then introduced
into ESCs by electroporation. After drug selection, we obtained
750 drug resistant colonies. We first screened for the
recombination by genomic PCR and then confirmed the
recombination by Southern hybridization, in which the wild-
type and targeted locus gave rise to bands of 17.2 kbp and
14.5 kbp, respectively (Figure 2B). We found that one out of the
750 clones had the correct homologous recombination. The
ECAT11
WT/EGFP ESCs were positive for GFP fluorescence, but
became negative when differentiation was induced by retinoic
acid treatment (Figure 2C), thus suggesting that our reporter
recapitulated the endogenous expression. By introducing the
ESC clone into blastocysts, we established chimeric, and
subsequently ECAT11 knock-in, heterozygous mice.
ECAT11-EGFP localization in mouse embryos
To study the expression of ECAT11 during mouse develop-
ment, we observed the developmental process from egg to
embryonic day (E) 15.5 embryos using ECAT11-EGFP expression
(Figure 2D). While EGFP fluorescence was not observed until
themorula stage, an obvious expression was noted in the whole
blastocyst from the blastula stage (Figure 2D (i)–(vi)). The
expression was conspicuous in both embryonic and extraembry-
onic tissue onE7.5 (Figure 2D (vii)). GFP fluorescence gradually
decreased until E9.5, and had completely disappeared by E10.5
(Figure 2D (viii), (ix)). The signal of ECAT11-EGFP appeared
again at E13.5 inthe interdigitregions and lower jaw (Figure 2D
(x), (xi)). ECAT11-EGFP expression was also observed in the testes
and ovaries (Figure 2D (xii)). The fluorescence in the lower jaw
and inter-digit regions was detectable until E15.5 (Figure 2D (xiii)).
The effects of ECAT11 disruption in the entire mouse and
ESCs
To elucidate the effects of ECAT11 disruption, we compared the
ECAT11
EGFP/EGFP and WT mice. The interbred ECAT11
WT/EGFP
mice yield F1 pups, including ECAT11 null mice, according to the
Mendelian rule (Wild-type:ECAT11
WT/EGFP:ECAT11
EGFP/EGFP=
43:74:46). ECAT11-null mutant mice were normal in gross
appearance and by the X-ray analyses(Figure S1), and were found
to be fertile. Therefore, ECAT11
EGFP/EGFP is dispensable in mouse
development and fertilization.
To investigate the functions ofECAT11 in ESCs, we obtained
25 blastocysts from intercrosses of ECAT11
WT/EGFP hetero-
zygous mice and established 14 ESC lines. Among them, two
lines were wild type, nine were ECAT11
WT/EGFP, and 3 were
ECAT11
EGFP/EGFP. We usedonewildtype line (#6202), two
ECAT11
WT/EGFP lines (#7491 and #7061), and three
ECAT11
EGFP/EGFP lines (#6206, #7571 and #7572), as well as
the RF8 parental ESC line, in the subsequent analyses. A Western
blot analysis confirmed the absence of ECAT11 expression
in the ECAT11
EGFP/EGFP ESC lines (Figure 3A). Immunos-
taining also confirmed the absence of the ECAT11 protein in
ECAT11
EGFP/EGFP ESC lines (Figure 3B). In wild-type ES cells,
immunofluorescent microscopy using an anti-ECAT11 antibody
detectedECAT11inthecytoplasminaspottypattern,whichissimilar
to that of the L1ORF1 protein (Figure 3B) [22]. No such signal was
detected in the ECAT11
EGFP/EGFP ESC lines (Figure 3B).
ECAT11
EGFP/EGFP ESCs showed normal morphology and
proliferation (Figure 3C). They also showed similar global gene
expression profiles asthe wild type ESCs as determined by a
microarray analysis (Figure 3D). ECAT11
EGFP/EGFP ESCs did not
exhibit significant change in comparison with wild-type ESCs
(.2-fold, p,0.05). When subcutaneously transplanted into
residues at a given position, black letters on a green background; consensus residues derived from the occurrence of .50% of a single residue at a
given position, red letters on a yellow background; consensus residues derived from a completely conserved residue at a given position, green letters
on a white background; residues weakly similar to the consensus residue at a given position. (B)The expression profiles of mouse (upper)and human
(lower) ECAT11. RNA was isolated from ESCs, differentiated ESCs, human ESCs (H9), human dermal fibroblasts (HDF), an embryonic tumor cell line
(NCR-G3)and various tissues from adult mice or humans, and were used for an RT-PCR analysis. The differentiation of mouse ESCs was achieved by
retinoic acid (RA) treatment (300 nM) for 7 days. The amplification cycles are shown at right. NAT1 was used as a loading control.
doi:10.1371/journal.pone.0020461.g001
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EGFP/EGFP ESCs formed terato-
mas, which consisted of various tissues of all three germ layers,
such as neuronal cells, epithelium, and cartilage (Figure 3E).
Therefore, ECAT11 is also dispensable for theself-renewal of
pluripotent ESCs.
Induction of ECAT11 expression in mouse embryonic
fibroblasts
We examined whether ECAT11 can be activated by pluripo-
tency-associated transcription factors (Oct4 (O), Sox2 (S), Klf4 (K),
c-Myc (M) and Nanog (N)) in mouse embryonic fibroblasts
(MEFs). We introduced various combinations of the five
transcription factors into MEFs established from ECAT
EGFP/EGFP
embryos (Figure 4). Two days after the transduction of 31 possible
combinations, we examined the expression of ECAT11-EGFP by
a flow cytometer. No single factor was able to induce EGFP
fluorescence. However, we observed arapid and robust (.10%)
activation by three combinations, OSK, OSKM, and OSKMN
(Figure 4). Modest activation (,5%) was obtained by OK, OKN,
and OKM. These data indicated that ECAT11 is rapidly activated
by Oct3/4 and Klf4, together with Sox2.
ECAT11 is dispensable for iPSC generation
The rapid activation of ECAT11 in MEFs by OSK(M)
prompted us study whether iPSCs can be generated without
ECAT11. We introduced the four reprogramming factors
(OSKM) by retroviruses into ECAT11
EGFP/EGFP MEFs. Five
days after transduction, cells were re-seeded onto SNL feeder cells
and selected with puromycin. Approximately 20 days after
transduction, we observed many puromycin-resistant colonies.
These cells were expandable, and showed a morphology and
proliferation similar to ESCs (Figure 5A). These cells expressed
pluripotency-associated genes, such as Nanog, at comparable
levels to those in ES cells (Figure 5B). They also formed teratomas
containing various tissues representing all three germ layers
(Figure 5C). These data demonstrated that ECAT11 is dispensable
for mouse iPSC generation.
Discussion
In this study, we generated ECAT11-EGFP knock-in/-out mice
and studied the expression and functions of ECAT11. We
confirmed that ECAT11 is expressed in early mouse embryos
and undifferentiated ES cells. We also found that ECAT11 is
rapidly activated during iPSC generation. Despite this specific
expression, ECAT11-deficient ES cells were normally self-renewed
and remained pluripotent. We were able to generate iPSCs from
ECAT11-null fibroblasts. These data demonstrated that ECAT11
is dispensable for the induction and maintenance of pluripotency,
despite its specific expression.
It has been reported that a lot of truncated sequences derived
from L1 are dispersed in the mouse genome [25], indicating that
these fragments might work as complementary factors for
ECAT11. Indeed, some dispersed L1 sequences are still active in
several types of somatic cells [26],[27] and germ cells at various
developmental stages [28]. L1 expression was also observed in the
blastocyst, from which ESCs are derived [29]. The L1ORF1
protein binds to RNA in a sequence non-specific manner [30]. In
addition, other putative proteins containing Transposase_22 are
interspersed in the mouse genome (EMBL-EBI: IPR004244
Transposase_22: http://www.ebi.ac.uk/interpro/IEntry?ac=
IPR004244). Therefore, these related proteins might compen-
sate for a loss of function of the ECAT11 protein.
The expression of ECAT11-EGFP in MEFs was effectively
promoted by the forced expression of three factors, Oct4, Sox2
and Klf4. This induction was further enhanced by c-Myc. Previous
reports of studies using chromatin-immunoprecipitation assays
showed that the promoter region of ECAT11 is occupied by Klf4
and c-Myc in mouse ESCs [31],[32]. Oct4 and Sox2 have been
shown to regulate the transcriptional activity of target genes
through the interaction with their recognition sequences, octamer-
and SRY-binding sites, respectively. The database analysis of
transcription factor binding sites using TFSEARCH (http://
www.cbrc.jp/research/db/TFSEARCH.html) identified multiple
octamer- and SRY-binding sites in the 59- flanking region of the
mouse ECAT11 gene. However, genome wide mapping of Sox2
and Oct4 binding sites by ChIP-seq could not detect their
interaction in these regions in ESCs [32]. It therefore remains to
be determined whether Oct3/4 and Sox2 directly activate the
transcription of ECAT11.
In conclusion, we have herein demonstrated that ECAT11
disruption does not affect the function of ESCs, mouse
development or fertility. By using a reporter mouse, we found
that the ECAT11 promoter is rapidly activated by ectopic
expression of Oct4, Sox2 and Klf4. Nevertheless, iPSCs can be
generated from ECAT11-null fibroblasts. Therefore, ECAT11/
L1ltd1 is considered to be dispensable for the induction and
maintenanance of plutipotency, despite its specific expression.
Materials and Methods
Cell culture, induction of transcription factors and
reprogramming
ESCs (RF8mouse ES cell line [33] and all other embryonic stem
cell lines established in this research)were maintainedin DMEM
supplemented with 20% FBS(Invitrogen), 0.1 mM non-essential
aminoacids(Invitrogen), 2 mM L-glutamine(Invitrogen), 50 U/ml
penicillin-streptomycin(Invitrogen), 0.11 mM 2-mercaptoethano-
l(Invitrogen)and LIF on feeder layers of mitomycin C-treated SNL
cells [34] or gelatin coated dishes. As a source of leukemia
inhibitory factor (LIF), we used conditioned medium (1:1000
dilution) from Plat-E cell cultures that had been transduced with a
LIF expression vector. ESCs were passaged every 2 days. Plat-E
packaging cells, which were also used to produce retroviruses,
were maintained in DMEM containing 10% FBS, 50 units/
50 mg/ml penicillin/streptomycin, 1 mg/ml puromycin (Sigma),
Figure 2. Generation of the ECAT11-EGFP knock-in reporter and mice. (A) Schematic representations of the structures of the mouse ECAT11
gene (WT), targeting BAC (BAC), and targeted loci (Targeted). The positions of the probes (blue lines), and recognition sites of BspHI (B) are shown.
The black box indicates the ECAT11 coding region. Open arrowheads indicate the 39 screening primer pair that amplified only the recombinant allele.
DT-A: diphtheria toxin A, IRES: internal ribosomal entry site, Puro: puromycin resistance gene, bGHpA: bovine growth hormone poly A sequence, FRT:
flippase recognition target. (B) The results of the Southern blot analysis of ECAT11
WT/EGFP ESCs. (C)The morphology of the ECAT11
EGFP/EGFP ESCs
grown on gelatin-coated dishes. The phase and EGFP fluorescence images of undifferentiated (left panels) and differentiated (right panels) cells are
shown. Cells were cultured with RA for eight days before taking the photographs. Bars; 100 mm. (D) ECAT11-EGFP expression in mouse embryos.
Bright field and EGFP fluorescence images of fertilized eggs (i), 2 cells (ii), 4 cells (iii), 8 cells (iv), morulae (v), blastocysts (vi), E7.5 gastrulae (vii), E9.5
embryos (viii), E10.5 embryos (ix), E13.5 embryos (x), limbs of E13.5 embryos (xi), reproductive glands of E13.5 embryos; left, testis; right, ovary (xii),
and the E15.5 embryo of an ECAT
EGFP/EGFP mouse (xiii) are shown. WT: wild type. EGFP: ECAT11
EGFP/EGFP.
doi:10.1371/journal.pone.0020461.g002
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stem cells (WiCell) were maintained in Primate ES medium(Re-
proCELL, Japan) supplemented with 4 ng/ml recombinant
humanbasic fibroblast growth factor (bFGF, WAKO, Japan).
Retroviral transductions and induction of nuclear reprogramming
were performed as described previously [35].
Mice
All mice used in this study were bred and sacrificed
appropriately following code of ethics of animal research
committee in Kyoto University.The animal care and experimental
procedures of this subject were approved by the Animal Research
Committee, Kyoto University and carried out according to the
Regulation on Animal Experimentation at Kyoto University
(approval ID : I-6-5).
Construction of targeting vectors for targeted disruption
of ECAT11 in mouse ESCs
We purchasedthe bacterial artificial chromosome (BAC) clone
RP24-326M13 containing ECAT11 from the BACPAC resources
Figure 3. ECAT11 is dispensable for mouse ESCs. (A)A Western blot analysis of the ECAT11 expression in ESC lines. The data are shown in
duplicate. (B) Immunocytochemistry of ECAT11. Red: ECAT11, Blue: DAPI. Bars; 20 mm. (C)The proliferation of ECAT11 knock-in ESCs. Ten thousand
cells were plated, and counted on days2, 4, 6 and 8. We used 2 WT, 2 ECAT11
WT/EGFP, and 3 ECAT11
EGFP/EGFP ESC lines for this analysis. The data are
shown as the averagesand standard deviations. (D) Scatter plots showing a comparison of the global gene expression determined by the microarray
analyses between the WT and ECAT11
EGFP/EGFP ESCs. The data from 2 WT ESC lines and 3 ECAT11
EGFP/EGFP ESC lines cultured on gelatin coated dishes
were averaged and used for this analysis. (E)Hematoxylin and eosin staining of teratomas generated from ECAT11
EGFP/EGFP ESCs. The gross image
(upper left), neural tissue, gut-like epithelia, and cartilage are shown. The scale bars are 200 mm in the gross image and 100 mm in the other images.
doi:10.1371/journal.pone.0020461.g003
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Bridges), we replaced from the translation initiation site to exon 5
that contained the ECAT11 coding region with an EGFP-IRES-
Puro cassette and inserted a diphtheria toxin A cassette 8.7 kbp
upstream of the 59 arm. After linearization with BspTI, the
modified targeting vectors were introduced into RF8 ESCs by
electroporation. Genomic DNA isolated from puromicin-resistant
colonies was screened for homologous recombination by PCR,
and correct targeting was confirmed by a Southern blot analysis of
BspHI-digested DNA with a specific probe. The Southern blot
analysis was performed following the manufacturer’s protocols.
For the sequences of the primers and probes, see Table 1.
Generation of ECAT11-deficient mice and ESCs
The ECAT11 disrupted (ECAT11
WT/EGFP) heterozygous ESCs
were microinjected into C57BL/6 blastocysts and implanted into
pseudopregnantJcl:ICR females to obtain chimeric mice. The
chimeric founders were mated with each other or C57BL/6 mice
to generate heterozygous ECAT11
WT/EGFP mice, which were then
intercrossed to produce homozygous ECAT11
EGFP/EGFP mice. All
of the phenotype analyses were performed with littermates on a
mixed 129/Sv and C57BL/6 background.
To establish ECAT11
EGFP/EGFP ESCs, ECAT11
WT/EGFP or
ECAT11
EGFP/EGFP female mice were injected with 10 mgo f
tamoxifen (Sigma) and 1 mg of depo-provera (Sigma) subcutane-
ously on the third day after mating. Four days later, pregnant mice
were sacrificed, and embryos in diapause were flushed out of the
uterus by PBS supplemented with 10% FBS. These blastocysts
were cultured on SNL feeder cells in four-well plates in DMEM
supplemented with 10% FBS, 0.1 mM non-essential aminoacids,
2 mM L-glutamine, 50 U/ml penicillin-streptomycin, and 0.11
mM 2-mercaptoethanol. After 6 days, the central mass of each
explant was harvested, rinsed in PBS, and placed in a drop of
trypsin for 5 minutes. The cell mass was collected with a finely
drawn-out Pasteur pipette preloaded with medium, ensuring
minimal carryover of the trypsin. The cells were gently transferred
into a fresh well with medium containing 20% FBS. The resulting
primary ESC colonies were individually passaged into the wells of
four-well plates containing SNL feeder cell layers. Thereafter, cells
were expanded by trypsinization of the entire culture. Genotypes
of established clones were confirmed by genotyping PCR (For
primers, see Table 1).
RT-PCR and real-time PCR
Total RNA from mice was purified with the TRIzol reagent
(Invitrogen) and treated with a Turbo DNA-free kit (Ambion) to
remove genomic DNA contamination. Total RNA of dermal
fibroblasts and various tissues from adult humans were purchased
from STRATAGENEH and CELL APPLICATIONS, Inc. One
microgram of total RNA was used for the reverse transcription
reaction with ReverTraAce-A (Toyobo, Japan) and the dT20
primer, according to the manufacturer’s instructions. PCR was
performed with Ex Taq HS (Takara, Japan).
Generation of anti-ECAT11 polyclonal antibodies
The coding sequence of aa275 to 360 of ECAT11 was amplified
by PCR (For primers, see Table 1). The PCR product was
subcloned into pENTR/D-TOPO (Invitrogen), and was trans-
ferred into pDEST17 (Invitrogen) by LR recombination. After
introduction of the resulting expression vector, pDEST17-
mECAT11-275360, into BL21-AI E. coli (Invitrogen), recombi-
nant protein production was induced according to the manufac-
turer’s protocol. Histidine-tagged ECAT11 was purified using Ni-
nitrilotriacetic acid agarose (Qiagen) under denaturing conditions
in the presence of 8 M urea. After dialysis against 6 M urea, the
recombinant proteins were consigned to SCRUM Inc. to generate
anti-ECAT11 rabbit polyclonal antibodies.
Western blot analysis
The cells in a semiconfluent state were lysed with M-PER
(Thermo Scientific) supplemented with protease inhibitor cocktail
(Roche). Ten microliters of the cell lysate were separated by
electrophoresis on 8% SDS-polyacrylamide gels, then were
transferred to a polyvinylidinedifluoride membrane (Millipore),
and probed with the primary antibody against ECAT11 (1:1000)
or b-actin (1:5000, A5441, Sigma). Signals were detected with
anti-mouse IgG-HRP (1:3000, #7076, Cell Signaling) or anti-
rabbit IgG-HRP (1:2000, #7074, Cell Signaling).
Immunocytochemistry
ESCs were fixed with PBS containing 4% paraformal-
dehyde for 20 min at room temperature. After washing with
PBS, the cells were treated with PBS containing 5% normal goat
serum (Millipore), 1% bovine serum albumin (BSA, Nacalait-
esque), and 0.2% Triton X-100 for 45 min at room tempera-
t u r e .A f t e r3w a s h e dw i t hP B S ,8ml of primary antibody (anti-
ECAT11 rabbit whole serum) was diluted in 800 mlo fP B S
containing 1% BSA and added into blocked cells. The
secondary antibody used was cyanine 3 (Cy3)-conjugated goat
anti-Rabbit IgM (1:500, Millipore).
Teratoma formation
The cells were harvested by 0.25% trypsin/1 mM EDTA
treatment, collected into tubes, and centrifuged, and the pellets
were suspended in 10% FBS/DMEM. One million of the cells
were injected subcutaneously into the dorsal flank of a nude mouse
(CREA, Japan). Eight weeks after the injection, tumors were
dissected, weighed, and fixed with PBS containing 4% parafor-
maldehyde. Paraffin-embedded tissues were sliced and stained
with hematoxylin and eosin.
Cell proliferation assay
Ten thousand cells were plated in duplicate onto 60 mm gelatin
coated dishes. Before counting cells, these cultured dishes were
washed with 1 ml PBS and cells were dispersed with 500 mlo f
0.25% trypsin. Thereafter, 2 ml of medium were added, and 100 ml
of the suspension was used for counting. The number of cells was
counted on days 2, 4, 6, and 8 using a Z1 Coulter Particle Counter
(Beckman coulter). This procedure was repeated three times.
Microarray analysis
Total RNA from wild-type and ECAT11
EGFP/EGFP ESCs were
labeled with Cy3, and were hybridized to oligonucleotide
microarrays (Agilent) according to the manufacturer’s protocol.
Hybridization was repeated with ESCs representing two indepen-
dent wild-type clonesand three ECAT11
EGFP/EGFP clones. The
Figure 4. Activation of the ECAT11 promoter by forced expression of Oct4, Sox2 and Klf4. The expression of the ECAT11-EGFP
fluorescent marker was induced by various combinations of transcription factors. EGFP fluorescence was analyzed by flowcytometry two days after
retroviral transduction. O: Oct4, S: Sox2, K: Klf4, M: c-Myc, N: Nanog.
doi:10.1371/journal.pone.0020461.g004
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(Agilent). The data were analyzed using the GeneSpringGX ver.
11.5 software program (Agilent). Each chip was normalized to the
75th percentile of the measurements. The flag settings were set as
described below. Absent;Spot feature is not uniform, saturated or
population outlier, Marginal; spot feature is not positive or not
above background:, Present;spot feature is other than those above.
The genes having present flag in at least one out of the five
Figure 5. Generation of iPSCs from ECAT11
EGFP/EGFP MEFs. (A) Morphology of an ECAT11
EGFP/EGFP iPSC colony, which was picked on day 23
after induction of four factors (Oct4, Sox2, Klf4 and c-Myc) and cultured on feeder cells for three passages. Scale bars: 100 mm. (B) The expression
levels of three pluripotency markers (Nanog, ECAT1 and Zfp42), and four transcription factors (Oct4, Sox2, Klf4 and c-Myc). Total RNA was collected
from four clones of ECAT11
EGFP/EGFP iPSCs(686F1, 686I5, 686L5 and 686O2) established using four factors (Oct4, Sox2, Klf4 and c-Myc), and four clones
(686E1, 686H7, 686K1 and 686N1)established usingthree factors (Oct4, Sox2 and Klf4). The iPSCs selected with Fbx15 orthe Nanog reporter (20D17),
MEFs, and ES cells were also usedas controls. For reprogramming factor detection, RT–PCR analyses were performed with primers that amplified
endogenous transcripts only (endo) and transgene transcripts only (tg) to detect the viral vector silencing. (C) Hematoxylin and eosin staining of
teratomas generated from ECAT11
EGFP/EGFP iPSCs. Scale bars: 50 mm.
doi:10.1371/journal.pone.0020461.g005
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ECAT11
EGFP/EGFP ESCs and analyzed the result based on
unpaired t-statistics with Benjamini and Hochberg false discovery
rate (.2-fold change, p,0.05). Microarray data are available in
GEO (Gene Expression Omnibus, http://www.ncbi.nlm.nih.gov/
projects/geo/index.cgi) with the accession number GSE28145.
MEF establishment
MEFs were derived from ECAT11
EGFP/EGFP embryos at E13.5.
After removal of the head and gastrointestinal tract, the embryos
were minced, and dissociated with trypsin. The cell suspensions
were plated onto gelatin-coated dishes through 70 mm mesh. Five
days after plating, the established MEFs were counted, and 5610
6
cells were stored using freezing medium. The MEFs were thawed
and used for induction assays after one passage.
FACS analysis
Cells were harvested by incubation in 0.25% trypsin/1 mM
EDTA for 5 min at 37uC, and single-cell suspensions were
obtained by repetitive pipetting and transfer through a 70 mm cell
strainer. After washing with PBS supplemented with 3% FBS, cells
were resuspended in PBS containing 1/1000 volumes of DAPI
and analyzed by a FACSAria II instrument (BD Biosciences).
Dead cells were excluded by staining with DAPI. The data were
analyzed with the Diva 6.1 software program (BD Biosciences).
Supporting Information
Figure S1 X-ray analysis of ECAT11
EGFP/EGFP mice. X-
ray evaluation of ECAT11
EGFP/EGFP or WT mice (2-week-old).
(TIF)
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